Approaches to otolaryngic allergy emergencies.
The otolaryngic allergist should take every measure possible to prevent reactions during testing and treatment of the allergic patient. Because the risk of this rare complication cannot be completely eliminated, however, it is essential to be prepared for prompt recognition and proper treatment of an anaphylactic emergency. An emergency set, including airway management tools, oxygen, intravenous materials, and proper medication, is essential. The entire office staff should be educated to cope with the emergency. Finally, a medication history must be repeated at intervals to detect patients who are receiving beta blockers to either remove them from the patients' treatment regimen or to prepare for the special treatment of the patients on beta blockers.
Hunsaker
D H
DH
Department of Otolaryngology, Naval Medical Center, San Diego, USA.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000707:Anaphylaxis / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002985:Clinical Protocols; D003888:Desensitization, Immunologic / Q000009:adverse effects; D004347:Drug Interactions; D004630:Emergencies; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000175:diagnosis / Q000517:prevention & control* / Q000628:therapy; D007275:Injections, Intravenous; D008487:Medical History Taking; D010038:Otorhinolaryngologic Diseases / Q000175:diagnosis / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D010102:Oxygen Inhalation Therapy; D012119:Respiration; D012151:Resuscitation / Q000193:education; D012307:Risk Factors; D012882:Skin Tests / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D018926:Anti-Allergic Agents